Mark Theeuwes

Mark Theeuwes is currently serving as the Strategic Advisor at Somnia Therapeutics and as the Chief Operating Officer at Reunion Neuroscience. Mark is also a Member of the Board of Directors at the Epilepsy Foundation and the Principal at Pharmaceutical Services, LLC. With a background in biochemistry and extensive experience in various leadership roles within the pharmaceutical industry, Mark has contributed significantly to organizations such as Egalet Corporation, NPS Pharmaceuticals, and ViroPharma Incorporated.